Thank you for attending.
Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain at the synchronous in-person symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.
To obtain your CE credit:
After verification of attendance, within 48 hours of the program's completion, you will receive an email with a link to take the posttest, complete the evaluation, and claim your credit.
Thank you for attending. Please proceed to the post-test and evaluation to claim credit.
Thank you for attending this course. Please click "Next Page" to proceed to the posttest, evaluation, and claim your credit. You will have 2 weeks to claim your credit.
Thank you for attending. Please select "Next Page" to proceed.
Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain at the synchronous in-person symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.
To obtain your CE credit:
After verification of attendance, within 48 hours of the program's completion, you will receive an email with a link to take the posttest, complete the evaluation, and claim your credit.
This highly dynamic, interactive discussion will focus on optimizing outcomes for patients with neovascular age-related macular degeneration and diabetic eye disease.
Dr. Sophie J. Bakri will present data on real-world outcomes, discuss new and emerging therapies, and highlight the ideal patients for these therapies. A series of cases will further enrich the discussion.
This activity is supported by an unrestricted medical education grant from Genentech, a member of the Roche Group.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education, LLC is a COPE-accredited administrator.
This activity, COPE Activity Number 124220, is accredited by COPE for continuing education for optometrists for 1.5 hours.
Course #: 79068-TD
Activity #: 124220
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Sophie J. Bakri, MD
Professor and Chair
Department of Ophthalmology
Mayo Clinic
Rochester, MN
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Sophie J. Bakri, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Adverum, Allergan, Alimera, Apellis, Eyepoint Pharmaceuticals, Regenexbio, Genentech, Kala Pharmaceuticals, Novartis, and Roche.
The Evolve staff, planners, and reviewers have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group.
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Yewlin E. Chee, MD
Camila Ventura MD, PhD
Edward Wood, MD
Tony Capone Jr, MD
Katherine E. Talcott, MD
Nassim Abreu, MD
